T-cell homeostasis: The dark(ened) side of common variable immunodeficiency

Blood

Volumn 112, Issue 2, 2008, Pages 446-

  Giovannetti, Antonello ^a   Pierdominici, Marina ^a   Aiuti, Fernando ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN;

B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL COUNT; CELL EXPANSION; COMMON VARIABLE IMMUNODEFICIENCY; HOMEOSTASIS; HUMAN; LETTER; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; CYTOLOGY; IMMUNOLOGY; NOTE;

COMMON VARIABLE IMMUNODEFICIENCY; HOMEOSTASIS; HUMANS; T-LYMPHOCYTES;

EID: 85047683492     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-145045     Document Type: Letter

References (7)

1. Wehr C. Kivioja T, Schmitt C, et al. The EDROclass trial: defining subgroups in common variable immunodeficiency. Blood. 200S;111:77-85.
2. Bayry J, Hermine O. Webster DA, Levy Y, Kaveri SV. Gommon variable immunodeficiency: the immune system in chaos. Trends Mol Med. 2005;11: 370-376.
3. Goldacker S, Warnatz K. Tackling the heterogeneity of CVID. Gurr Opin Allergy Clin Immunol. 2005;5:504-509.
4. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277-286.
5. Giovannetti A, Pierdominici M, Mazzetta F, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol. 2007; 178:3932-3943.
6. Cunningham-Rundles C, Bodian C. Gommon variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34-48.
7. Cunningham-Rundles C, Bodian G, Ochs HD, Martin S, Reiter-Wong M, Zhuo Z. Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency. Clin Immunol. 2001;100:181-190.